Variant report
Variant | nsv1017687 |
---|---|
Chromosome Location | chr5:106227452-106240564 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs10464030 | chr5:106230234-106230235 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs569954316 | chr5:106230274-106230275 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs535648487 | chr5:106230286-106230287 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs149619549 | chr5:106230293-106230294 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs566369497 | chr5:106230296-106230297 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs534971607 | chr5:106230303-106230304 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs557756079 | chr5:106230322-106230323 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs577543689 | chr5:106230374-106230375 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs115618621 | chr5:106230383-106230384 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs111863694 | chr5:106230391-106230392 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs573733749 | chr5:106230404-106230405 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs542853645 | chr5:106230416-106230417 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs73204111 | chr5:106230424-106230425 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
14 | rs528411274 | chr5:106230462-106230463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs59631134 | chr5:106230474-106230475 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs555741757 | chr5:106230477-106230478 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs564540223 | chr5:106230499-106230500 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs533149534 | chr5:106230510-106230511 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs549907004 | chr5:106230513-106230514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs569816169 | chr5:106230561-106230562 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs529305355 | chr5:106230576-106230577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs549566891 | chr5:106230603-106230604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs76453250 | chr5:106230662-106230663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs535356739 | chr5:106230696-106230697 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs375231284 | chr5:106230698-106230699 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs56852424 | chr5:106230699-106230700 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs575907961 | chr5:106230713-106230714 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs71224899 | chr5:106230724-106230725 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs546136135 | chr5:106230742-106230743 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs558150887 | chr5:106230756-106230757 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs368231944 | chr5:106230768-106230769 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs189322765 | chr5:106230783-106230784 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs180820998 | chr5:106230829-106230830 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs556957324 | chr5:106230857-106230858 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs573796262 | chr5:106230868-106230869 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs534954104 | chr5:106230869-106230870 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs553163571 | chr5:106230876-106230877 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61080231 | chr5:106230879-106230880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs1580831 | chr5:106230898-106230899 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
40 | rs185569834 | chr5:106230925-106230926 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs148751436 | chr5:106230930-106230931 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs530668896 | chr5:106230955-106230956 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs1580832 | chr5:106231013-106231014 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
44 | rs572800188 | chr5:106231032-106231033 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs529367803 | chr5:106231039-106231040 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs549185986 | chr5:106231109-106231110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs559930770 | chr5:106231138-106231139 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs142265453 | chr5:106231147-106231148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs368146039 | chr5:106231167-106231168 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs188420761 | chr5:106231177-106231178 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Metanephric adenoma | 20802469 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Acute lymphoblastic leukemia | 17690704 | CNVD |
Gastrointestinal stromal cancer | 16982739 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Malaria | 21533027 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Cancer | 20164919 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Cancer | 16751803 | CNVD |
Intellectual disability | 22102821 | CNVD |
Breast cancer | 17603634 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Melanoma | 18172304 | CNVD |
Glioma | 20126413 | CNVD |
Breast cancer | 17393978 | CNVD |
Cancer | 21359685 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
adenomatous polyposis | 22470819 | CNVD |
Cancer | 22429812 | CNVD |
Cancer | 21637783 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Liposarcoma | 21253554 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Breast cancer | 21858162 | CNVD |
Leukemia | 17361228 | CNVD |
Myelodysplastic syndrome | 18508791 | CNVD |
5q-syndrome | 17576883 | CNVD |
Gastric cancer | 17908304 | CNVD |
Lung cancer | 16740712 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Urothelial carcinoma | 21177765 | CNVD |
Esophageal adenocarcinoma | 19417022 | CNVD |
Barrett''s syndrome | 19417022 | CNVD |
Lung cancer | 18438408 | CNVD |
Retinoblastoma | 22278416 | CNVD |
Bipolar disorder | 18458673 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Breast cancer | 21785460 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Hepatocellular carcinoma | 16750200 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Prostate cancer | 18632612 | CNVD |
Breast cancer | 17133270 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 16573809 | CNVD |
Cancer | 20164920 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
abnormal development | 18461090 | CNVD |
Colorectal cancer | 16774939 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Acute lymphoblastic leukemia | 21339820 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Chronic lymphocytic leukemia | 18922857 | CNVD |
Ovarian cancer | 21720365 | CNVD |
Neurocytoma | 17123091 | CNVD |
Salivary gland tumor | 18059337 | CNVD |
Breast cancer | 21509527 | CNVD |
Breast cancer | 16608533 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Lung cancer | 16773561 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr5:106230200-106231400 | Enhancers | Primary monocytes fromperipheralblood | blood |
2 | chr5:106230200-106231400 | Enhancers | Primary neutrophils fromperipheralblood | blood |
3 | chr5:106230600-106231400 | Enhancers | Monocytes-CD14+_RO01746 | blood |
4 | chr5:106230800-106231200 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
5 | chr5:106231400-106233400 | Weak transcription | Primary monocytes fromperipheralblood | blood |
6 | chr5:106233400-106234400 | Enhancers | Primary monocytes fromperipheralblood | blood |
7 | chr5:106240000-106240800 | Enhancers | iPS DF 19.11 Cell Line | embryonic stem cell |
8 | chr5:106240000-106241000 | Active TSS | HUES64 Cell Line | embryonic stem cell |
9 | chr5:106240200-106241000 | Active TSS | iPS-15b Cell Line | embryonic stem cell |
10 | chr5:106240200-106241200 | Active TSS | ES-I3 Cell Line | embryonic stem cell |
11 | chr5:106240200-106241400 | Enhancers | ES-UCSF4 Cell Line | embryonic stem cell |
12 | chr5:106240400-106240800 | Active TSS | H9 Cell Line | embryonic stem cell |